KINEMED Trademark

Trademark Overview


On Friday, October 31, 2003, a trademark application was filed for KINEMED with the United States Patent and Trademark Office. The USPTO has given the KINEMED trademark a serial number of 78321806. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 9, 2008. This trademark is owned by KineMed, Inc.. The KINEMED trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, rheumatoid arthritis, and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of psychiatric or cognitive disorders, namely, mood disorders, anxiety disorders, and disorders of learning and memory; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, and metabolic syndrome; pharmaceutical preparations for the treatment of cardiovascular diseases, namely, coronary artery disease, congestive heart failure, and cardiomyopathy; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory connective tissue diseases, inflammatory bowel disease, osteoarthritis, and wound healing; pharmaceutical preparations for the treatment of neurologic diseases, namely, multiple sclerosis, Alzheimer's disease, Park...

General Information


Serial Number78321806
Word MarkKINEMED
Filing DateFriday, October 31, 2003
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 9, 2008
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 15, 2005

Trademark Statements


Goods and Servicespharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, rheumatoid arthritis, and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of psychiatric or cognitive disorders, namely, mood disorders, anxiety disorders, and disorders of learning and memory; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, and metabolic syndrome; pharmaceutical preparations for the treatment of cardiovascular diseases, namely, coronary artery disease, congestive heart failure, and cardiomyopathy; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory connective tissue diseases, inflammatory bowel disease, osteoarthritis, and wound healing; pharmaceutical preparations for the treatment of neurologic diseases, namely, multiple sclerosis, Alzheimer's disease, Parkinson's disease, and cognitive disorders; pharmaceutical preparations for the treatment of dermatologic diseases, namely, psoriasis, atopic dermatitis, eczema, photowrinkling and aging, and skin pigmentation disorders; pharmaceutical preparations for the treatment of disorders relating to toxicological insult, namely, liver cirrhosis, liver fibrosis, and pulmonary fibrosis; pharmaceutical preparations for the treatment of reproductive disorders, namely, male infertility and female infertility; pharmaceutical preparations for the treatment of musculo-skeletal disorders, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, and cartilage degradation; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in cardiology; pharmaceutical preparations for use in gynecology and urology; pharmaceutical preparations for use in endocrinology; pharmaceutical preparations for use in rheumatology; pharmaceutical preparations for use in neurology; pharmaceutical preparations for use in allergies and infectious diseases (immunology); pharmaceutical preparations for use in gerontology.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 24, 2003
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKineMed, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEmeryville, CA 946082012

Party NameKineMed, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEmeryville, CA 946082012

Trademark Events


Event DateEvent Description
Tuesday, August 12, 2008ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Tuesday, August 12, 2008ABANDONMENT - NO USE STATEMENT FILED
Thursday, November 29, 2007EXTENSION 5 GRANTED
Thursday, November 29, 2007EXTENSION 5 FILED
Thursday, November 29, 2007TEAS EXTENSION RECEIVED
Friday, November 9, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 7, 2007EXTENSION 4 GRANTED
Thursday, June 7, 2007EXTENSION 4 FILED
Thursday, June 7, 2007TEAS EXTENSION RECEIVED
Monday, January 22, 2007EXTENSION 3 GRANTED
Monday, November 27, 2006EXTENSION 3 FILED
Monday, November 27, 2006TEAS EXTENSION RECEIVED
Tuesday, October 10, 2006ASSIGNED TO EXAMINER
Monday, June 12, 2006EXTENSION 2 GRANTED
Tuesday, May 30, 2006EXTENSION 2 FILED
Tuesday, May 30, 2006TEAS EXTENSION RECEIVED
Monday, December 5, 2005EXTENSION 1 GRANTED
Friday, November 18, 2005EXTENSION 1 FILED
Friday, November 18, 2005TEAS EXTENSION RECEIVED
Tuesday, June 7, 2005NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 15, 2005PUBLISHED FOR OPPOSITION
Wednesday, February 23, 2005NOTICE OF PUBLICATION
Thursday, December 30, 2004LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 17, 2004ASSIGNED TO LIE
Monday, December 13, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 10, 2004TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 6, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 6, 2004TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 9, 2004NON-FINAL ACTION E-MAILED
Monday, June 7, 2004ASSIGNED TO EXAMINER
Monday, November 24, 2003NEW APPLICATION ENTERED IN TRAM